Cabaletta Bio Statistics
NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.97-0.05 (-2.48%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Cabaletta Bio by the numbers
Cabaletta Bio has a market capitalization of $334.0 million based on 169.55M shares outstanding. With trailing EPS of $-1.51, Cabaletta Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.9% below its 50-day average and 32.3% below its 200-day average.
Average daily trading volume is 4.76M shares, or about $9.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CABA valuation vs. peer median
| Metric | CABA | Peer median | Difference |
|---|---|---|---|
| Market cap | $334.00M | $342.05M | -2% |
| Avg. volume | 4.76M | 689.06K | +591% |
Peer median across 8 companies: ARTV, AGEN, OCGN, CCCC, SCTX, FENC, KYTX, SRZN.
Valuation
- Market cap
- $334.00M
- EPS (TTM)
- $-1.51
- Shares outstanding
- 169.55M
Price and trading
- Previous close
- 2.02
- Open
- 1.98
- Day range
- 1.94 – 2.06
- 52-week range
- 1.83 – 4.23
- 52-week change
- -15.09%
- Beta
- —
- Volume
- 2.14M
- Average volume
- 4.76M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 334.00M
- Forward Pe
- -1.66
- Eps
- -1.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.23
- Week52 Low
- 1.83
- Avg Volume
- 4.76M
- Shares Outstanding
- 169.55M
- Ma50
- 2.73
- Ma200
- 2.91
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -53.43%
- Pct From52w Low
- 7.65%